BID3.67 ASK4.31
Open3.96 Previous Close4.08
Pre-Market- After-Market-
 - -  - -%
Target Price
1.20 
Analyst Rating
Moderate Sell 3.70
Potential %
-70.59 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     45.92
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     33.22
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap177.13M 
Earnings Rating
Buy
Price Range Ratio 52W %
61.97 
Earnings Date
29th Apr 2021

Today's Price Range

3.944.08

52W Range

1.135.89

5 Year PE Ratio Range

-13.1018.50

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Strong Buy
Performance
1 Week
7.37%
1 Month
34.65%
3 Months
25.54%
6 Months
133.14%
1 Year
130.29%
3 Years
30.77%
5 Years
-17.74%
10 Years
2.66%

TickerPriceChg.Chg.%
CCM4.080.00000.00
AAPL132.992.63002.02
GOOG2 285.8820.44000.90
MSFT255.852.60001.03
XOM55.87-0.1300-0.23
WFC40.500.47001.17
JNJ161.25-1.7200-1.06
FB312.46-0.5600-0.18
GE13.600.15001.12
JPM156.281.16000.75
Financial StrengthValueIndustryS&P 500US Markets
0.80
1.20
0.84
6.63
-9.00
Leverage Ratio -15.20
ProfitabilityValueIndustryS&P 500US Markets
-12.30
-199.30
-199.30
-144.50
-
RevenueValueIndustryS&P 500US Markets
11.75M
0.42
-19.87
-28.38
Earnings HistoryEstimateReportedSurprise %
Q02 20160.21-0.06-128.57
Q01 20160.12-0.11-191.67
Q04 2015-0.09-0.58-544.44
Q03 20150.020.08300.00
Q02 20150.020.13550.00
Q01 20150.070.1271.43
Q04 2014-0.02-
Q03 20140.070.1271.43
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.030.00-
12/2019 QR-0.030.00-
12/2020 FY-0.210.00-
12/2021 FY-0.140.00-
Next Report Date29th Apr 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume8.54K
Shares Outstanding43.41M
Trades Count152
Dollar Volume49.93K
Avg. Volume55.02K
Avg. Weekly Volume10.34K
Avg. Monthly Volume63.03K
Avg. Quarterly Volume53.24K

Concord Medical Services Holdings Limited ADS (Each represents three) (NYSE: CCM) stock closed at 4.08 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 8.54K shares and market capitalization of 177.13M. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 738 people. Concord Medical Services Holdings Limited ADS (Each represents three) CEO is Jianyu Yang.

The one-year performance of Concord Medical Services Holdings Limited ADS (Each represents three) stock is 130.29%, while year-to-date (YTD) performance is 48.91%. CCM stock has a five-year performance of -17.74%. Its 52-week range is between 1.13 and 5.89, which gives CCM stock a 52-week price range ratio of 61.97%

Concord Medical Services Holdings Limited ADS (Each represents three) currently has a PE ratio of -2.00, a price-to-book (PB) ratio of 3.03, a price-to-sale (PS) ratio of 8.91, a price to cashflow ratio of 30.60, a PEG ratio of 2.32, a ROA of -10.78%, a ROC of -34.46% and a ROE of 628.21%. The company’s profit margin is -%, its EBITDA margin is -199.30%, and its revenue ttm is $11.75 Million , which makes it $0.42 revenue per share.

Of the last four earnings reports from Concord Medical Services Holdings Limited ADS (Each represents three), there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Concord Medical Services Holdings Limited ADS (Each represents three)’s next earnings report date is 29th Apr 2021.

The consensus rating of Wall Street analysts for Concord Medical Services Holdings Limited ADS (Each represents three) is Moderate Sell (3.7), with a target price of $1.2, which is -70.59% compared to the current price. The earnings rating for Concord Medical Services Holdings Limited ADS (Each represents three) stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Concord Medical Services Holdings Limited ADS (Each represents three) has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Concord Medical Services Holdings Limited ADS (Each represents three) has a Neutral technical analysis rating based on Technical Indicators (ADX : 21.77, ATR14 : 0.29, CCI20 : -141.62, Chaikin Money Flow : -0.16, MACD : -0.14, Money Flow Index : 25.76, ROC : -24.58, RSI : 34.54, STOCH (14,3) : 13.94, STOCH RSI : 0.34, UO : 26.11, Williams %R : -86.06), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Concord Medical Services Holdings Limited ADS (Each represents three) in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0
0
Moderate Buy
0 (0.00 %)
0
0
Hold
0 (0.00 %)
0
0
Moderate Sell
1 (100.00 %)
0
0
Strong Sell
0 (0.00 %)
0
0
Summary RatingModerate Sell
3.70
--

Concord Medical Services Holdings Limited ADS (Each represents three)

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers and diagnostic imaging centers and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.

CEO: Jianyu Yang

Telephone: +86 1059036688

Address: 36 North Third Ring Road, Beijing 100013, , CN

Number of employees: 738

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

60%40%

Bearish Bullish

50%50%

News

Stocktwits